Lyell Immunopharma, Inc. (LYEL)

22.71 +0.07 (+0.31%) USD  |  NASDAQ  |  Feb 06, 16:00
22.72 +0.02 (+0.07%) After-Hours: 20:00
More

Lyell Immunopharma Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade